Nothing Special   »   [go: up one dir, main page]

AU2212299A - Compositions and methods for the treatment of tumor - Google Patents

Compositions and methods for the treatment of tumor

Info

Publication number
AU2212299A
AU2212299A AU22122/99A AU2212299A AU2212299A AU 2212299 A AU2212299 A AU 2212299A AU 22122/99 A AU22122/99 A AU 22122/99A AU 2212299 A AU2212299 A AU 2212299A AU 2212299 A AU2212299 A AU 2212299A
Authority
AU
Australia
Prior art keywords
tumor
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22122/99A
Inventor
David Botstein
Audrey Goddard
Austin L. Gurney
Kenneth J. Hillan
David A. Lawrence
Margaret Ann Roy
William I. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2212299A publication Critical patent/AU2212299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU22122/99A 1998-01-05 1999-01-05 Compositions and methods for the treatment of tumor Abandoned AU2212299A (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US7044098P 1998-01-05 1998-01-05
US60070440 1998-01-05
US8350098P 1998-04-29 1998-04-29
US60083500 1998-04-29
US8641498P 1998-05-22 1998-05-22
US60086414 1998-05-22
US8874298P 1998-06-10 1998-06-10
US60088742 1998-06-10
US10778398P 1998-11-10 1998-11-10
US60107783 1998-11-10
US10930498P 1998-11-20 1998-11-20
US60109304 1998-11-20
PCT/US1999/000106 WO1999035170A2 (en) 1998-01-05 1999-01-05 Compositions and methods for the treatment of tumor

Publications (1)

Publication Number Publication Date
AU2212299A true AU2212299A (en) 1999-07-26

Family

ID=27557028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22122/99A Abandoned AU2212299A (en) 1998-01-05 1999-01-05 Compositions and methods for the treatment of tumor

Country Status (2)

Country Link
AU (1) AU2212299A (en)
WO (1) WO1999035170A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037640A2 (en) * 1998-12-22 2000-06-29 Genentech, Inc. Compositions and methods for the treatment of tumor
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US8212004B2 (en) 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
WO1999010492A1 (en) 1997-08-26 1999-03-04 Zymogenetics, Inc. Adipocyte-specific protein homologs
US20020192752A1 (en) 1998-09-09 2002-12-19 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
EP1132477A4 (en) * 1998-11-20 2003-05-07 Fuso Pharmaceutical Ind Novel serine proteases bssp4
US20050053983A1 (en) 1998-11-20 2005-03-10 Fuso Pharmaceutical Industries, Ltd. Novel serine protease BSSP4
JP2002541795A (en) * 1999-04-12 2002-12-10 リボザイム・ファーマシューティカルズ・インコーポレーテッド Regulation of repressor genes using nucleic acid molecules
US20030022233A1 (en) 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
US6458564B1 (en) * 1999-08-31 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease T
US6426199B1 (en) * 1999-08-31 2002-07-30 Ortho-Mcneil Pharmaceutical, Inc. Dna
US7282562B2 (en) 1999-08-31 2007-10-16 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP1208201B9 (en) * 1999-08-31 2009-08-19 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP2003518925A (en) * 1999-11-01 2003-06-17 ナラン ウトゥク Novel genes TZAP7 / A, TZAP7 / B, and TZAP7 involved in T cell activation, and uses thereof
WO2001087979A2 (en) 2000-05-12 2001-11-22 Amgen Inc. Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
WO2001096528A2 (en) * 2000-06-15 2001-12-20 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
ES2609016T3 (en) 2000-06-16 2017-04-18 Human Genome Sciences, Inc. Antibodies that bind immunospecifically to BLyS
US7879328B2 (en) 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
CA2423519A1 (en) * 2000-08-10 2002-02-14 Pharmacia Corporation A new slit-like protein obtained from a cdna library from hs-5 stromal cell line
AU2001288260A1 (en) * 2000-08-15 2002-03-13 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20030091565A1 (en) 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
US6632028B1 (en) * 2000-08-25 2003-10-14 Vtr Optoelectronics, Inc. Apparatus and method for aligning an optical fiber with an optical device
AU2002342669C1 (en) 2001-05-11 2010-10-07 Amgen, Inc. Peptides and related molecules that bind to TALL-1
WO2002094192A2 (en) 2001-05-24 2002-11-28 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (april)
AU2002358126A1 (en) * 2001-12-14 2003-06-30 Bayer Aktiengesellschaft Regulation of human short chain dehydrogenase/-reductase
US20060281146A1 (en) * 2002-09-11 2006-12-14 Genetech, Inc. Novel compositions and methods for the treatment of immune related diseases
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2006067210A1 (en) 2004-12-23 2006-06-29 Laboratoires Serono S.A. Bcma polypeptides and uses thereof
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
CA2629306A1 (en) 2005-11-23 2007-05-31 Genentech, Inc. Methods and compositions related to b cell assays
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
WO2007140907A1 (en) * 2006-06-07 2007-12-13 Bayer Healthcare Ag Use of serine endopeptidases 22 (prss22) as a therapeutic or diagnostic target
JOP20140087B1 (en) 2013-03-13 2021-08-17 Amgen Inc Proteins specific for baff and b7rp1 and uses thereof
US9458246B2 (en) 2013-03-13 2016-10-04 Amgen Inc. Proteins specific for BAFF and B7RP1

Also Published As

Publication number Publication date
WO1999035170A9 (en) 2000-03-09
WO1999035170A2 (en) 1999-07-15
WO1999035170A8 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
AU6147401A (en) Compositions and methods for the treatment of cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU9016898A (en) Methods and compositions for treatment of restenosis
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2821295A (en) Compositions and methods for the treatment of tumors
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU3065999A (en) Compositions and methods for treatment of asthma
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
AU5333298A (en) Compositions and methods for tumour therapy
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2420101A (en) Method and composition for the treatment of pain
AU2566201A (en) Compounds and methods for the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase